Licensing and collaborative opportunities for new partners

Senexis is actively seeking to enter into collaborations and licensing deals with established pharmaceutical and emerging biotechnology companies.

Out-licensing

Senexis plans to offer a balanced portfolio of pre-clinical or early clinical licensing opportunities to the pharmaceutical sector, particularly in the more costly areas of clinical development.

For further information outside Japan, please contact Mark Treherne by email or call +44 (0) 1223 496160. For Japan, please contact Dr Jun Ishiguro at SC Consulting, Inc. (see below).

  Japanese Representative

  SC Consulting, Inc.
  27F, Tokyo Sankei Bldg.,
  1-7-2, Ote-Machi, Chiyoda-Ku
  Tokyo 100-0004
  Tel: +81(0)3 3242 6358
  Fax: +81(0)3 3242 6359
  Email: info@sc-consultinc.com

  Web: http://www.sc-consultinc.com/